Single-use biopharma market expected to reach $11.2 billion by 2029, driven by growth factors.

From GlobeNewswire: 2025-01-23 13:11:00

The demand for Single-use Technologies for Biopharmaceuticals is projected to grow from $6.5 billion in 2024 to $11.2 billion by 2029, with a CAGR of 11.6%. The market report covers trends, growth drivers, and profiles leading companies like Sartorius AG and Thermo Fisher Scientific.

Factors driving market growth include the rising demand for personalized medicine, new product introductions, and the adoption of monoclonal antibodies. Single-use systems in downstream operations save time and reduce contamination risks in drug production.

The market report projects a CAGR of 11.6% from 2024 to 2029, with single-use bioreactors dominating the market in 2029. North America has the highest market share, and leading companies include Merck KGaA and Lonza.

Related reports cover Pharmaceutical Filtration and 3D Cell Cultures, offering insights into market trends and technologies. For more information or to purchase these reports, contact [email protected].

BCC Research provides objective market research reports to help businesses make informed decisions. Industry analysts offer unbiased assessments of market opportunities, free from noise and hype.



Read more at GlobeNewswire: Single-Use Biopharma Market Set to Achieve $11.2 Billion by